30 August 2022
Farxiga significantly reduced the risk of cardiovascular death or worsening of heart failure in patients with mildly reduced or preserved ejection fraction in DELIVER Phase III trial…
25 August 2022
Tagrisso approved in Japan for the adjuvant treatment of patients with early-stage EGFR-mutated lung cancer…
Lynparza approved in Japan as adjuvant treatment for patients with BRCA-mutated HER2-negative high-risk early breast cancer…
24 August 2022
Condensed half-yearly financial report 30 June 2022…
Camellia Plc (CAM.L) issues the following update on trading for the year and confirms the interim results release date….
23 August 2022
Unaudited half-year results for the six months ended 30th June 2022…
19 August 2022
“HICL” or the “Company” and, together with its subsidiaries, the “Group”, the London-listed infrastructure investment company managed by InfraRed Capital Partners Limited (“InfraRed” or the “Investment Manager”)….
17 August 2022
Preliminary Results for the year ended 30 April 2022…